Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Neurobiol Aging. 2019 Mar 27;79:75–82. doi: 10.1016/j.neurobiolaging.2019.03.011

Table 4.

Reports of means, SDs, and numbers of observations for GABA in the IFG and the SM areas on different time points within different treatment groups.

Time point Treatment group Mean (SD) of IFG GABA Mean (SD) of SM GABA Number of observations
Before tDCS 2.03 (0.57) 2.09 (0.29) 11
After tDCS 1.52 (0.52) 2.24 (0.29) 11
2month tDCS 1.61 (0.46) 2.19 (0.45) 7
Before Sham 1.40 (0.37) 1.93 (0.47) 11
After Sham 1.33 (0.59) 2.23 (0.38) 11
2month Sham 1.48 (0.48) 2.05 (0.50) 10